Where does Alkermes Pharma Ireland Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Alkermes Pharma Ireland Limited ranks #2,870 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Alkermes Pharma Ireland Limited hold?

Alkermes Pharma Ireland Limited holds 133 US utility patents granted between 2015 and 2025, spanning 12 technology areas.

What is Alkermes Pharma Ireland Limited's Innovation Score?

Alkermes Pharma Ireland Limited has an Innovation Score of 42.0 out of 100 (top 32% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Alkermes Pharma Ireland Limited focus on?

Alkermes Pharma Ireland Limited's top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 124 patents, ranking #149 of 7,163 assignees active in that subclass. Grants appear in 12 CPC subclasses total.

Is Alkermes Pharma Ireland Limited's patent grant rate increasing or decreasing?

Alkermes Pharma Ireland Limited's recent grant velocity is -44% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Alkermes Pharma Ireland Limited's patents?

Alkermes Pharma Ireland Limited's patents average 14.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Alkermes Pharma Ireland Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Alkermes Pharma Ireland Limited

USPTO PatentsView assignee record - 133 granted patents across 12 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Alkermes ranks #2,870 of 49,997 tracked US assignees by granted-patent volume, with 133 patents across 12 technology areas.

#2,870
of 49,997 US assignees by volume: Top 32%
by Innovation Score (42.0/100): 14.7
avg claims per patent: -44%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R2870 · Foreign Corporation #2,870 · 133 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MID 133 grants
TOP-DECILE #2,870/49,997
PHOTO-FINISH Alpha and Omega…
CPC-FOCUS A61K · 12 areas
INNOV-PAR 42.0/100
CLAIMS-RICH 14.7 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -44% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Alpha and Omega Semiconductor (Cayman) Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Alkermes’s 42.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 16.9 pts (40%) Velocity 4.0 pts (10%) Breadth 12.2 pts (29%) Claim depth 8.8 pts (21%)

Qualcomm Incorporated · highest

85
Alkermes Pharma… · this assignee

42
Cereno Scientific AB · near

42
HotaluX · near

42
HZO · near

42
Universite DE Liege · near

42
3D Lighting… · lowest

7

What this shows Alkermes's Innovation Score is 42.0/100 (top 32% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Alkermes?

Each dot is one of Alkermes’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Alkermes’s own 14.7 claims/patent is at or below the 16.7 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Alkermes vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Alkermes's grants concentrate

Alkermes Pharma Ireland Limited is a focused PatentsView assignee: 12 CPC subclasses with 93.2% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2018 (23 grants) versus a trough of 6 in 2023. By volume, Alkermes sits between Universite DE Strasbourg and Beijing Sensetime Technology Development Co., Ltd.

Alkermes's three-year grant acceleration

From 2019–2021 to 2022–2024, Alkermes Pharma Ireland Limited moved from 40 to 24 grants (0.60x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,448. See the growth leaderboard.

Universite DE Str…

134
Vioptix

134
Wayne Fueling Sys…

134
Andritz

133
Alpha and Omega S…

133
Arctic Cat

133
BBY Solutions

133
Beijing Sensetime…

133
Alkermes Pharma I… ◀

133

What this shows Alkermes holds 133 patents at rank #2,871, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Alkermes

By rank, the assignees closest to #2,871 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Alkermes's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Alkermes, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Alkermes ranks #149 of 7,163 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (42 here).

HZO, Inc. 42 HotaluX, Ltd. 42 Universite DE Liege 42 Cereno Scientific AB 42

Similar claim depth

Nearest assignees by average claims per patent (14.7 here).

Leadtrend Technology Corporation 14.7 avg MiMedx Group, Inc. 14.7 avg FU Ding Electronical Technology (JIASHAN) Co., Ltd. 14.7 avg Sensors Incorporated 14.7 avg

Alkermes's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

42 Top 32% higher than 68% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Alkermes Pharma Ireland Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	21	15.8%
2016	10	7.5%
2017	10	7.5%
2018	23	17.3%
2019	18	13.5%
2020	15	11.3%
2021	7	5.3%
2022	11	8.3%
2023	6	4.5%
2024	7	5.3%
2025partial year	5	3.8%

Which technologies does Alkermes Pharma Ireland Limited patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 124

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 116

C07D - Heterocyclic Compounds 81

C07C - Acyclic OR Carbocyclic Compounds 22

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 14

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 7

C07K - Peptides 6

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 4

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 2

Y10T - Technical Subjects Covered BY Former US Classification 1

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

Y10S - Technical Subjects Covered BY Former Uspc Cross-reference ART Collections [XRACs] AND Digests 1

Top 12 of 12 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Alkermes Pharma Ireland Limited's patent record in context - here's where to go next.

Alkermes Pharma Ireland Limited's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 93.2% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #2,870 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Alkermes Pharma Ireland Limited against Universite DE Strasbourg, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 42.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.